Saimiri monkeys immunized with a Plasmodium falciparum merozoite polypeptide of 41 kD mol wt are resistant to a blood challenge infection that induces a fulminant infection in control monkeys. The sera of the immunized monkeys reacted, as shown by the indirect immunofluorescence technique, with the apical part of the merozoites from five isolates or clones of P. falciparum. Whether the immunogen was dissolved in nonionic detergent (NP-40) or in sodium dodecyl sulfate (SDS) had a marked influence on the level of protection in immunized monkeys. Thus, monkeys immunized with the antigen solubilized in a nonionic detergent developed much lower parasitemia than monkeys immunized with denatured antigen (antigen eluted from SDS polyacrylamide gel electrophoresis).
Introduction
Passive injection of human antimalarial antibodies inhibits the proliferation of asexual blood stages of Plasmodium falciparum in vivo (1) . These antibodies seem to act against merozoites (2) , which are the invasive forms of the parasite during the asexual cycle.
Several malarial antigens including a polypeptide of 41 kD have been identified at the merozoite surface by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)' analysis and autoradiography of surface labeled purified merozoites (3, 4). This 41-kD polypeptide may be identical to a polypeptide of similar molecular weight immunoprecipitated by monoclonal antibodies (5) . These monoclonal antibodies present two interesting features: first, as shown by the indirect fluorescence technique, they react with two small spots located at the apical part of the merozoite's surface (probably the rhoptries) as recently confirmed by immunoelectromicroscopy (Aikawa, M., and L. H. Perrin, unpublished data), and secondly, they inhibit in vitro the growth of P. falciparum asexual blood stages (5 (7) . Schizonts and merozoites were purified by differential centrifugation and the pellet was extracted with 7 vol of lysis buffer (7). The lysate was centrifuged at 30,000 g for 20 min at 4°C and the supernatant (120 ml total) was used for subsequent purification.
Purification of the 41-kD polypeptide. 40 ml of schizont and merozoite extract supplemented with 2 X 108 cpm of methionine labeled SGE2 extract used as tracer, were mixed overnight at 4°C with 20 ml of immunoabsorbent. The mixture was poured into a 30-ml column, washed with 120 ml of lysis buffer containing 1% NP-40, and then washed with 60 ml of lysis buffer containing 0.05% Polypeptides were eluted at 4°C with 0.1 M glycine HC1, pH 3, supplemented with 0.05% NP-40. 4-ml fractions were collected and immediately neutralized by the addition of 0.5 M Tris-HCl, pH 9.5. Presence of the 41-kD polypeptide in the eluted fractions was monitored by analysis of subsamples on SDS-PAGE stained with Coomassie blue and autoradiographed (7, 8) . Fractions containing the antigen were pooled, dialyzed against water overnight, lyophilized, and reconstituted in a volume of 3 ml (procedure repeated three times). 5 ml of this preparation containing 170 ,ug/ml of protein as measured by protein assay (Bio-Rad Laboratories, Richmond, CA) were applied on 3-mm thick 8% SDS-PAGE (procedure repeated five times). The 41-kD band was identified on small gel strips, stained with Coomassie blue, cut with a razor blade in small pieces, and electroeluted in dialysis bags (9) . The electroeluted preparation of 4 ml containing 180 /Ag/ml of protein was called "SDS antigen," whereas the fraction eluted from the immunoabsorbent was called "NP-40 antigen." different sites, the first time with 0.5 ml saline mixed with Freund's complete adjuvant, and the second and third times with 0.5 ml saline mixed with Freund's incomplete adjuvant 16 were precipitated by protein A (7). The immunoprecipitates were analyzed on 8% SDS-PAGE and autoradiography (7, 8) .
Results
Blood smears of the cell pellet used as starting material showed more than 85% schizonts, 15% of normal erythrocytes and other asexual blood stages, free merozoites (not counted), and pigment (not counted). Most of the pigment was removed by centrifugation. 1,590 ,g ofthe 41-kD polypeptide was recovered by affinity chromatography from 120 ml of the schizont and merozoite extract. Analysis of the recovered fraction showed a thick band of41 kD; the 82-kD polypeptide weakly recognized by two of the monoclonal antibodies used for the preparation of the immunoabsorbent was not detectable on optimally loaded gel (Fig. I A) , but was found in the washed-through fractions using immunoprecipitation (data not shown). There was no detectable difference in purity between the NP-40 41-kD preparation and the SDS 41-kD preparation (Fig. 1 A) . Prechallenge sera of the monkeys immunized with both antigenic preparations reacted by IFA, on preparation of SGE2 parasites, diffusely with mature schizonts and with two small spots located on merozoites (pattern similar to the reactivity obtained using the monoclonal antibodies coupled to the immunoabsorbent). IFA for their reactivity with five different isolates or clones of P. falciparum. The four sera tested at a dilution of 1/100 had the same reactivity with parasites from the five preparations. The antibody response of the two groups of immunized monkeys was determined more quantitatively using an ELISA assay. The results reported in Table I show that monkeys immunized with the 41-kD SDS antigen had very high titers against the SDS antigen but that both groups of monkeys had relatively similar titers against the NP-40 41 kD antigen.
The prechallenge sera of both groups of immunized monkeys precipitated a [35S]methionine labeled polypeptide of 41 kD; one serum precipitated both a 41-kD polypeptide and a 105-kD polypeptide (Fig. 1 B) . Similar results were obtained using [35Slmethionine-labeled extracts of SGE2 or Palo Alto as starting material.
After blood induced challenge infection, the four control monkeys developed very high parasitemia and were treated with quinine and Fansidar (Hoffmann-La Roche, Inc.) when their parasitemia reached 20% (Fig. 2) . Monkeys immunized with the 41 kD SDS antigen also had relatively high parasitemia whereas monkeys immunized with the NP-40 41 kD antigen had low peak parasitemia of 0.01%, 0.008%, 0.09%, and 1.2%. All but one of the monkeys immunized with the NP-40 41 kD antigen spontaneously recovered. This single immunized monkey was in poor general condition and required amputation of part of its tail because of extensive necrosis. Antimalarial treatment was administrated to this monkey 15 d after challenge (parasitemia, 1.2%) to prevent further deterioration of its condition. Weekly monitoring of blood smears of all monkeys for 4 mo after challenge did not reveal recrudescent patent parasitemia except for the three untreated monkeys of the group immunized with NP-40 41 kD. In these monkeys a very low grade parasitemia was observed between days 22 and 40 with peak parasitemia of 0.04%, 0.08%, and 0.18%. None of the monkeys suffered from late complications in relation to the experiments described here. 
Discussion
These experiments indicate that Saimiri monkeys immunized with a 4 1-kD polypeptide, probably located in the rhoptries of P. falciparum merozoites, are at least partially resistant to a blood induced challenge infection that induced a fulminant infection in control monkeys. The results are similar to those obtained using whole merozoites and/or schizonts as immunogens (11, 12, 13, 14) . The protective effect induced by immunization with the 41-kD polypeptide is probably not dependent on strain specific determinant, on the basis of several observations. First, the immunized monkeys were challenged with an isolate Palo-Alto different from the isolate (SGE2) used for purification of the 4 1-kD polypeptide. Second, antigenic diversity has not been detected on the 41 kD using monoclonal antibodies (6) (5) .
The experiments reported here also suggest that the conformation of the 41-kD polypeptide greatly affects the quality of the immune response. Immunization with the 41 SDS polypeptide induced very high levels of antibodies directed against the SDS antigen but comparatively low levels of antibodies against the native antigen. By comparing the efficiency of parasite control achieved by the two groups of immunized monkeys, it seems that high levels of antibodies against the 41 SDS antigen are poorly effective. The group of monkeys immunized with the NP-40 41 kD antigen suffered from a relapse with low parasitemia but clearly achieved the best control of the malaria infection. However, the antibody titer of this group of monkeys against the NP-40 41-kD antigen is lower than in the group of monkeys immunized with the 41 SDS antigen. This observation may be related to a difference in the quality (avidity) of antibodies raised in the two groups of monkeys. Alternatively, it may be that the 41-kD antigen is more efficient in its native form as inducer of cell mediated responses important for the control of malaria infection (19) .
Finally, the possibility exists that trace contaminants that may be present in a higher concentration in the NP-40 41-kD preparation may alter the above interpretation of the results. In this respect, further investigations are needed to establish if a precursor processed product relationship exists between high molecular weight polypeptide(s) and the 41-kD polypeptide (one of the monkey's sera precipitated a polypeptide of 105 kD). In relation to this aspect, we have not detected any structural analogy (7; and footnote 2) between the 41-kD polypeptide and two high molecular weight polypeptides of 140 apd 200 kD, which have previously been shown to induce a protective immunity (7) . Whether a cumulative effect can be obtained by using a mixture of the three polypeptides for immunization remains to be clarified.
